Company ProfilePremium

Titomic Limited

Company Profile Analysis

Ticker: TTT.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Titomic Limited - Company showcase

Year Founded & Workforce

2014

Titomic Limited logo

Titomic Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Titomic Limited Overview

Titomic is a small-cap advanced-manufacturing company built around a proprietary solid-state metal deposition process, Titomic Kinetic Fusion™ (TKF™). TKF is a form of cold spray, originally co-developed with Australia's CSIRO. It accelerates metal powder to supersonic velocity so the particles bond without melting, which allows Titomic to manufacture, coat and repair metal components. Over 2024–2026 the company moved from an Australian equipment vendor with a Dutch low/medium-pressure systems arm to a US-headquartered "production, repair and sustainment" business inside the US and allied defence industrial base. Its centre of gravity is now a 59,000 sq ft Huntsville, Alabama plant, which is AS9100-certified. Revenue remains small (about A$10M on a trailing basis) and losses are large (about A$19M in H1 2026 alone). The investment case therefore rests on converting a defence-prime, US Navy/USAF, aerospace MRO, energy and semiconductor pipeline into recurring production revenue before balance-sheet constraints force further heavy dilution.


Company self-description (latest filings)

Titomic's standard description in its 2026 ASX releases is broadly as follows. It calls itself an advanced manufacturing company with global operations. It specialises in large integrated solutions for industrial-scale metal additive manufacturing, coating and repair using its patented kinetic fusion cold spray technology. It provides OEM production and R&D services to aerospace, defence, shipbuilding, oil and gas, mining and automotive customers, with global sales and support run from the Huntsville headquarters and local presence in Australia and Europe (Q2 2026 Quarterly Activities Report, 31 Jul 2026). In the TP2025 annual report release (27 Feb 2026), management described the company as a "production-scale cold spray manufacturing company operating inside the U.S. and allied defense industrial base." Later releases (Oct 2026) add semiconductors to the end-market list.

Independent characterisation

Titomic is best understood as a hybrid with three activities:

  1. An industrial capital-equipment OEM. It sells cold spray systems across low-, medium- and high-pressure classes, which customers install for their own repair, coating or additive production. This was historically the dominant revenue line, anchored by the Dutch Dycomet heritage (acquired 2021).

  2. A contract manufacturer and repair house. It produces qualified parts, near-net-shape builds and repairs in Huntsville and Heerenveen. Defence primes, US Navy and USAF depots, oil and gas operators, aerospace MRO shops and a semiconductor customer use it for low-rate and full-rate production.

  3. An aftermarket and recurring-revenue platform. This covers powder supply, consumables, spare parts, training, service, leasing and "repair-as-a-service." Management has flagged this as the strategic pivot toward higher-margin recurring revenue (FY2025 Annual Report release).

Revenue model mix

Revenue streamNatureCurrent weight (qualitative)Evidence
System sales (TKF™ / Dycomet-heritage machines)One-off capital equipmentHistorically the largest; still material (e.g., US$5.0M USAF system, Sep 2026; Lufthansa Technik >A$1.2M, May 2026; Compass Systems >US$400k for two TKF™623 systems, Oct 2026)ASX releases 2026
Contract production / partsProgram-based; LRIP moving to full-rateEmerging; semiconductor full-rate contract worth about A$1.5M in 2027 and up to A$3.2M in 2028Semiconductor release, 7–8 Oct 2026
Repair, coating and restoration servicesJob-based; potentially recurringEmerging (oil and gas emergency repair, EOS refurbishment, US Navy evaluations)Q2 2026 4C report
Qualification / R&D / testing servicesContracted studiesMaterial in count, small in value (Bechtel Plant Machinery US$250k; Royal Netherlands Army €150k; US$534k across four US orders)Oct 2026 releases
Powder, consumables, spares, training, leasingRecurring aftermarketStated strategic priority; not separately quantifiedFY2025 Annual Report release
IP licensingRoyalty / licenceNot a disclosed revenue line—

Titomic does not publicly disclose an exact split between product, service, subscription and licensing revenue in the sources reviewed. Qualitatively:

Value-chain position

Titomic sits in the midstream of the metal-component value chain, between metal powder suppliers upstream and OEMs, defence primes, depots and MRO operators downstream. Through its own production cells it also increasingly acts as a Tier-2/Tier-3 supplier to defence primes. Unlike laser powder-bed fusion vendors, its process is solid-state, which avoids melt-related distortion and phase changes. It suits large parts, dissimilar-metal combinations, refractory metals, and field-deployable or shipboard repair.

Customer types and end-markets

Defence (US and allied): US defence primes (unnamed prime's Early Manufacturing Development program), US Navy (Fleet Readiness Center Southwest via Compass Systems; Pacific Battle Damage Exercise 2026; submarine industrial base via Bechtel Plant Machinery), US Air Force (Tinker AFB depot system), Royal Netherlands Army, and a US military research organisation (CRADA).

Aerospace and MRO: Lufthansa Technik (Hamburg), NASA (Space Act Agreement, Feb 2026).

Energy / oil and gas: a major oil and gas operator (repair qualification and emergency repair), Saudi Arabia and Norway contracts (about A$550k, Sep 2026), DNV qualification for in-field aluminium corrosion coatings, and a global energy technology company (TKF™623 order).

Semiconductor: an undisclosed customer of Titomic Europe on full-rate production.

Rail / transportation: Deutsche Bahn (Jan 2026).

Industrial / AM ecosystem: EOS (component refurbishment), plus universities and research institutes as legacy Dycomet customers.

Strategy

Stated strategy (themes from the FY2025 annual report, TP2025 annual report, Investor Day 2026 and quarterly reports)

  1. "American-headquartered" defence-industrial-base positioning. Become, in the CEO's Q2 2026 framing, the premier advanced manufacturing company supporting the US and allied defence industrial base.

  2. Pivot from machines to services and recurring revenue. Move to a high-margin service and leasing model underpinned by powder supply, training and repair-as-a-service (FY2025 Annual Report release).

  3. Production-pathway conversion. Move programs through qualification, then low-rate initial production (LRIP), then full-rate production. The TP2025 report emphasised the transition from technical validation toward production integration.

  4. Vertical integration. Build an end-to-end manufacturing enterprise (machining, metrology, pre/post-processing) rather than remain an equipment vendor (Q2 2026 report).

  5. Diversified end-markets toward 2030: Defence and Aerospace; Oil and Gas / Maritime; MRO / Aviation; Transportation; Systems, Powder and Leasing; with semiconductors added in 2025–2026.

  6. Corporate re-domiciliation to the US, with a possible future US exchange listing "at an appropriate time" (12 Mar 2026).

Strategic initiatives in the last 24 months

InitiativeDateDetails / targetsStatus
Huntsville global HQ and manufacturing hubOpened Jun 202559,000 sq ft; AS9100 (Apr 2026); manufacturing build-out "substantially complete" (Jul 2026)Complete; second hall in planning
Change of fiscal year-end to 31 DecAnnounced Aug 2025Align with US and Netherlands subsidiariesComplete
US redomiciliation via scheme of arrangementAnnounced 12 Mar 2026; SID 12 May 2026Titomic, Inc. (Delaware) to become parent; ASX trading via CDIs; independent expert RSM Corporate Australia; advisers Norton Rose Fulbright Australia and Fluet & AssociatesPending; implementation now expected by 30 Nov 2026 (revised 24 Sep 2026)
Non-dilutive US financing2025–2026About US$24M OSC loan flagged Aug 2025. In 2026 the company targeted US$25M across EXIM (Make More in America) and OSC; the same 4C also says US$25M from each, which is internally inconsistent. JP Morgan engaged as adviser. EXIM direct loan of about US$10M progressing (Sep 2026).In progress; EXIM feedback was expected in Q3 2026 and OSC in Q4 2026
Other grants and funding2,025€800k Dutch Ministry of Economic Affairs (3D PK) grant secured. In progress as at Aug 2025: US DPA Title III, SBIR/STTR, and Australian National Reconstruction Fund (A$5M).Mixed
Equity raisesOct 2024; Jul 2025; Sep 2026A$30M; A$50M; A$16.5M (A$6M facility and equipment, A$6M working capital and reserves, A$2.3M technology/automation/digital, balance for hires)Completed
TKF™ Tactical (shipboard)May–Jul 2026Redesign from Navy feedback at PBDE 2026Demonstrated
Strategic advisory groups (US and Europe)2025–2026Defence market accessEstablished
Cost restructure15 Oct 2026About A$3.0M annualised savings; A$0.6M one-off cost; complete by end Oct 2026Under way
ESG / sustainability commitments—No formal emissions targets or ESG program disclosed in reviewed sources—

Medium-term targets and guidance

TargetSource / dateStatus of credibility
US$750M annual revenue by 2030FY2025 Annual Report release, 28 Aug 2025Aspirational. Requires about 100-fold growth from a trailing revenue of about A$10M (about US$6.5M).
About A$50M (or US$50M) revenue target discussed at Investor Day 2026, alongside recurring defence contractsInvestor Day summary, Mar 2026 (Quartr)—
13 "conversion programs" with illustrative 2026–2030 revenue potential of US$250–430M (explicitly not forecasts or contracted revenue)A$16.5M placement materials, Sep 2026Illustrative only
Revenue growth for the remainder of 2026, from defence, energy, maritime sustainment and machine salesAppendix 4D H1 2026Near-term guidance (qualitative)
Cash flow and EBITDA break-even during 2027Q2 2026 4C; placement; restructureKey monitorable
Semiconductor contract revenue of about A$1.5M in 2027 and up to about A$3.2M in 20288 Oct 2026Contract-specific

Products & Services

Titomic does not publish a public price list, so pricing is "not publicly disclosed" unless inferred from disclosed contract values (shown as indicative).

Systems (equipment)

ProductDescription / capabilitiesTarget customerLatest version / yearPricing (disclosed or implied)
TKF™ 3250Flagship large-format high-pressure TKF™ production system installed at Huntsville; used for large structural builds, refractory and high-strength alloysTitomic's own production; defence primes; large depotsInstalled at Huntsville during its first operating year (Jun 2025–Jun 2026)—
TKF™ 1000High-pressure production/R&D system installed at HuntsvilleProduction; R&D partnersInstalled 2025–2026—
TKF™ 623Medium-pressure cold spray system; DNV-qualified (with low-pressure systems) for in-field aluminium corrosion coatingsNavy depots (FRC Southwest), energy companies, MROCurrent; orders Sep–Oct 2026Implied about US$200k per system (two systems for more than US$400k, Compass Systems PO, 14 Oct 2026)
TKF™ 523Low-pressure portable cold spray system for coatings and repairMRO, oil and gas field service, maritimeCurrent—
TKF™ TacticalTKF™ 523 redesigned into a pelican-case, ship-hatch-compatible unit running on shipboard air and power, developed from US Navy feedback at PBDE 2026; demonstrated 14–15 Jul 2026US Navy shipboard / expeditionary repair2026 (prototype / demonstration stage)—
Turnkey low-pressure systems (Europe)Dycomet-heritage turnkey low-pressure systems with software, lab support and servicingAerospace MRO (Lufthansa Technik Hamburg), automotive, academiaOngoingLufthansa Technik contract more than A$1.2M (US$830k) for additional capability including a turnkey low-pressure system (May 2026)
High-pressure systems for depotsCold spray manufacturing system for a major USAF maintenance depotUS Air ForceContract 14 Sep 2026US$5.0M contract (system configuration not specified)
Legacy very-large TKF high-pressure cell (Melbourne)Large-scale additive system built around 2017 to showcase titanium AMHistoric demonstrator2017–2018Not applicable

Manufacturing and production services

OfferingDescriptionTarget customerStatus / flagship example
Contract production (LRIP → full-rate)Qualified production of components using TKF™Semiconductor equipment supply chain; defence primesFull-rate semiconductor contract (Titomic Europe, Oct 2026) following a 2025 LRIP run
Early Manufacturing Development (EMD) buildsPrototype/production articles with proprietary multi-material combinationsLeading US defence prime (unnamed)Article delivered Jun 2026 and used in a test (Q2 2026 report)
Refractory-metal manufacturingBuilds using strategic refractory metal inventory (more than A$0.7M purchased Q2 2026)Defence munitions/propulsion programsOngoing
Qualification and materials testingDeposition and mechanical testing (titanium alloy, high-strength steel, aluminium alloy, wear-resistant coatings)US defence/research customersProgram due for completion by end Nov 2026 (Sep 2026 orders)

Repair, coating and sustainment services

OfferingDescriptionTarget customerFlagship example
Rapid component repairRestoration of worn or damaged parts in days or weeksOil and gas, defence, AM OEMsOne-week emergency repair preventing an oil and gas production shutdown; EOS refurbishment in under a week (Q2 2026)
Corrosion-protection coatingsIn-field thermal-spray-aluminium alternativeOil and gas / maritimeDNV Statement of Qualification (Apr 2026)
Battle damage repairFrontline repair prototype developmentRoyal Netherlands Army€150k prototype contract (Oct 2026)
Submarine industrial-base repair materialsEvaluation of advanced repair materials/processesBechtel Plant Machinery (US Navy)Initial US$250k contract (Oct 2026)
Repair-as-a-serviceBundled service modelIndustrial customersStated strategic model (FY2025 Annual Report release)

Aftermarket and recurring

OfferingDescriptionStatus
Powder supplyMetal powders for installed TKF™ baseStated recurring pillar; revenue not disclosed
Spare parts and consumablesNozzles, wear parts, service kitsOngoing (Dycomet heritage)
Training and certificationOperator and process trainingOngoing
LeasingSystems leasing ("Systems, Powder & Leasing" named among 2030 revenue pillars)Stated pillar; size not disclosed
Software / AR toolsAugmented-reality support for cold spray systems (announced around Q1 FY2025)Feature, not separately monetised

Financial Narrative

Income statement

Sources: S&P Global Market Intelligence via StockAnalysis.com (income statement and cash flow, accessed Oct 2026). EBITDA is operating income plus D&A. Pre-tax income is derived from the S&P pretax margin. Company-reported headline revenue: FY2024 A$5.9M; FY2025 A$8.1M (+37%) (FY2025 Annual Report release, 28 Aug 2025). The difference from the S&P figures reflects inclusion of other income (e.g., grants and R&D tax incentives) in the S&P "total revenue" line. Net loss FY2025 of A$19.89M is consistent across sources. For FY2023, one aggregator reports a net loss of A$15.33M against S&P's A$15.71M; discrepancy flagged.

Margins (%)

Revenue CAGR FY2022–FY2025 (S&P basis): about 21.0% per year (A$5.32M to A$9.43M). On company headline revenue, FY2024–FY2025 growth was 37%.

Post-FY2025 periods (company-reported)

Sources: TP2025 Annual Report summary (27 Feb 2026, via Quartr); Appendix 4D H1 2026 (31 Aug 2026, via Quartr summary); Appendix 4C Q2 2026 (31 Jul 2026). Data conflict: one aggregator (StockAnalysis) shows H1 2026 revenue growth of +23.3%. The company's Appendix 4D figure of -11.1% is used here as the primary source.

Commentary — income statement. Titomic's revenue base has roughly doubled since FY2022, but the cost base has grown faster. Three inflections stand out:

  1. FY2024 was the "efficiency" year. Gross margin reached 35.9% and the operating loss narrowed to A$11.0M as Dycomet-heritage system sales scaled in Europe and overhead was cut after the FY2023 crisis.

  2. FY2025 marked the US build-out. Gross margin collapsed to 12.0%, and S&P data indicate negative gross profit in the trailing period to Dec 2025. Under-absorbed Huntsville capacity, inter-company equipment transfers and start-up production costs drove this. Operating losses almost doubled to A$19.8M, with stock-based compensation rising to A$6.0M as management was recruited with equity.

  3. TP2025 and H1 2026 confirm a burn rate of about A$18–19M of net loss per half. That is roughly four times half-yearly revenue, as Titomic absorbs US manufacturing, certification, qualification and redomiciliation costs ahead of revenue.

Management's explicit response is the Oct 2026 restructure (about A$3.0M of annualised savings) and the 2027 cash flow and EBITDA break-even target.

Balance sheet

Source: S&P Global Market Intelligence via StockAnalysis.com (balance sheet), from Titomic annual reports FY2022–FY2025 and TP2025. PP&E at 31 Dec 2025 included land A$10.79M, buildings A$2.24M, machinery A$11.13M and construction in progress A$9.87M.

Latest (30 Jun 2026) disclosed balance-sheet items. Cash A$14.26M. Loan facility from First National Bank of Pulaski of A$5.82M total (A$4.95M drawn), at 6.12% interest, secured by a US$4.0M (A$5.8M) term deposit earning about 3.3%. The facility is non-amortising and not due while it remains secured; the company plans to repay or refinance it on reaching break-even (Appendix 4C Q2 2026). The Appendix 4C wording leaves it unclear whether the pledged term deposit sits within the reported A$14.26M cash balance or alongside it; this is not resolved in the reviewed filing.

Commentary — balance sheet. The balance sheet was transformed by about A$80M of equity raised across Oct 2024 (A$30M) and Jul 2025 (A$50M). Equity went from negative at June 2023 to A$47.8M at December 2025, and assets shifted into US land, buildings and production equipment. Intangibles are nil: Titomic does not carry capitalised IP on its balance sheet, and the Dycomet goodwill was written off historically.

The common-stock and retained-earnings lines moved between FY2024 (A$75.2M / -A$84.6M) and FY2025 (A$23.1M / -A$23.0M). This is consistent with a capital reduction applied against accumulated losses, an accounting reclassification with no cash effect.

From December 2025 to June 2026 cash fell by A$21.5M in six months. The September 2026 A$16.5M placement (about A$15.6M net, analyst estimate) restored pro-forma liquidity to roughly A$30M before Q3 2026 burn. That is still only about four to five quarters of runway at the H1 2026 operating plus investing burn rate, absent the targeted non-dilutive debt.

Cash flow

Sources: FY2022–FY2025 from S&P via StockAnalysis.com. TP2025 operating cash flow and capex are derived (S&P TTM to 30 Jun 2026 less Appendix 4C H1 2026 year-to-date) and should be treated as indicative. TP2025 equity is the company-announced A$50M raise; the S&P aggregation shows a higher figure that could not be reconciled and is flagged.

H1 2026 cash flow (Appendix 4C, AUD M): operating -14.28; investing -6.63; financing +0.27; FX -0.87. Q2 2026 alone: operating -8.26 (vs -7.1 in Q1); investing -2.30 (vs -4.4 in Q1); customer receipts 1.48, which was lower than anticipated because A$0.5M of payments slipped into July and some orders moved into Q3.

Commentary — cash flow. Titomic has never generated positive operating cash flow. The step-change in burn from FY2025 onward is structural rather than cyclical: US headcount, a second production hall, certification and redomiciliation costs. Investing outflows are now tapering as the Huntsville build-out is "substantially complete" (Q2 2026 4C). Management's stated mitigants are customer-receipt growth in H2 2026, the A$3.0M restructure, and about US$25M of targeted non-dilutive funding from US EXIM and the Office of Strategic Capital (OSC). On the EXIM component, a direct loan of about US$10M was reported in Sep 2026 as progressing through EXIM's internal underwriting.

Ratios

Computable ratios (fiscal year-end basis)

Notes: TP2025 ROA and asset turnover are six-month, non-annualised figures. FY2023 debt-to-equity is negative because shareholders' equity was negative (A$-0.71M).

Ratios not meaningful (n/m) given persistent losses

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment

SegmentFY2022FY2023FY2024FY2025

Australia segment revenue (AUD Mn)

4.383.013.854.96

USA segment revenue (AUD Mn)

0.030.370.543.92

Europe segment revenue (AUD Mn)

1.452.705.207.27

Intersegment eliminations (AUD Mn)

-0.54-1.59-1.89-6.72

Total revenue S&P basis (AUD Mn)

5.324.497.709.43

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Segment Margins & Growth (%)

SegmentFY2023FY2024FY2025

Australia YoY growth (%)

-31.327.928.8

USA YoY growth (%)

1,133.345.9625.9

Europe YoY growth (%)

86.292.639.8

Revenue by Segment (%)

SegmentFY2022FY2023FY2024FY2025

Australia share of gross segment revenue (%)

74.649.640.030.8

USA share of gross segment revenue (%)

0.56.15.624.3

Europe share of gross segment revenue (%)

24.744.454.345.0

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025

Revenue S&P basis (AUD Mn)

5.324.497.709.43

Gross profit (AUD Mn)

0.751.072.761.13

Operating income (AUD Mn)

-16.12-12.55-11.04-19.79

EBITDA derived (AUD Mn)

-14.36-10.90-10.88-19.45

Pre-tax income derived (AUD Mn)

-16.97-15.71-11.66-19.95

Net income (AUD Mn)

-16.97-15.71-11.89-19.89

EPS basic and diluted (AUD)

-0.09-0.07-0.01-0.02

Dividends per share (AUD)

0000

Stock-based compensation (AUD Mn)

3.322.024.166.03

Depreciation and amortisation (AUD Mn)

1.761.650.160.34

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025

Gross margin (%)

14.123.835.912.0

Operating margin (%)

-303.0-279.7-143.5-210.0

EBITDA margin (%)

-270.0-242.8-141.3-206.3

Net margin (%)

-319.0-350.0-154.5-210.9

Cash Flow

MetricTP2025 (6M to 31 Dec 2025)H1 2026 (6M to 30 Jun 2026)

Revenue (AUD Mn)

5.274.87

Revenue change vs prior comparable period

Not comparable (12-month comparative)

-11.1% vs H1 2025

Net loss after tax (AUD Mn)

-17.85-19.35

Net loss change

—

+45.3% wider vs H1 2025

Total comprehensive loss attributable to owners (AUD Mn)

—-20.23

Cash at period end (AUD Mn)

35.7714.26

Customer receipts (AUD Mn)

—

4.85 (Appendix 4C YTD)

Net operating cash flow (AUD Mn)

-21.1 (derived: S&P TTM to Jun-26 less 4C H1 2026)

-14.28

Net investing cash flow (AUD Mn)

—-6.63

Balance Sheet and Share Count (M)

MetricFY2022FY2023FY2024FY2025TP2025

Total assets (AUD Mn)

14.826.358.0835.1070.55

Cash and short-term investments (AUD Mn)

7.631.472.738.9335.77

Short-term debt incl current leases (AUD Mn)

0.371.430.730.854.85

Long-term debt incl leases (AUD Mn)

1.050.700.3911.3411.08

Total debt incl leases (AUD Mn)

1.422.131.1112.1915.92

Net debt (AUD Mn; negative = net cash)

-6.210.66-1.623.26-19.85

Shareholders equity (AUD Mn)

7.41-0.711.0314.8247.81

Goodwill and intangibles (AUD Mn)

0.550000

Property plant and equipment (AUD Mn)

3.420.540.5620.1029.30

Inventory (AUD Mn)

2.112.733.464.173.44

Working capital (AUD Mn)

6.111.022.447.5831.08

Shares outstanding period end (M)

202.53238.991,011.001,326.001,599.00

Cash Flow (FY2022–TP2025)

MetricFY2022FY2023FY2024FY2025TP2025

Operating cash flow (AUD Mn)

-9.68-10.72-6.23-14.72-21.06

Capital expenditure (AUD Mn)

-1.07-0.93-0.90-14.90-3.08

Free cash flow (AUD Mn)

-10.75-11.65-7.13-29.62-24.14

Equity issued gross (AUD Mn)

12.425.1010.2530.1150.00

Dividends paid (AUD Mn)

00000

Share buybacks (AUD Mn)

00000

Financial Ratios (x) and Returns & Leverage Ratios (%)

MetricFY2022FY2023FY2024FY2025TP2025

Current ratio (x)

2.291.211.492.034.07

Total debt to equity (x)

0.19-3.001.080.820.33

ROA net loss over ending assets (%)

-114.5-247.4-147.2-56.7-25.3

Asset turnover revenue over ending assets (x)

0.360.710.950.270.07

Financial Analysis

RatioAssessment

ROE

n/m. Equity was negative or near zero in FY2023–FY2024, producing distorted values; FY2025 net loss of A$19.9M against average equity of about A$7.9M implies roughly -250%

ROIC

n/m (negative NOPAT in all years)

Net debt / EBITDA

n/m (negative EBITDA in all years)

Interest coverage

n/m (negative EBIT); cash interest paid rose to A$0.89M in the trailing period to Dec 2025 (S&P)

Cash conversion cycle

Not computed. Payables and receivables are small relative to inventory, and inventory of about A$3.4–4.2M against negative or small gross profit implies very slow turns; customer deposits (unearned revenue A$2.16M at Jun-25, A$0.68M at Dec-25) partially fund working capital

Revenue by Region

RegionFY2022FY2023FY2024FY2025

Australia (APAC) revenue (AUD Mn)

4.383.013.854.96

USA (Americas) revenue (AUD Mn)

0.030.370.543.92

Europe (EMEA) revenue (AUD Mn)

1.452.705.207.27

Region Margins & Growth (%)

RegionFY2023FY2024FY2025

Australia growth (%)

-31.327.928.8

USA growth (%)

1,133.345.9625.9

Europe growth (%)

86.292.639.8

Share Price History

DatePrice (AUD)ContextSource

Sep 2016

0.20

IPO price

Stockhead

Jun 2025

0.30

Maybank block purchase (8M shares, A$2.4M)

TipRanks

Jul 2025

0.25 (approx.)

A$50M raise / 200M shares

ASX; TipRanks

10 Oct 2025

0.49

Insider/institutional trade price (approx. peak)

Simply Wall St insider data

12 Mar 2026

0.21

Redomicile announcement

InvestSMART

13 May 2026

0.24

Scheme Implementation Deed

InvestSMART

28 Aug 2026

0.170

Pre-placement close

Placement release

2 Sep 2026

0.140

Post-placement (-20.6%)

Kalkine

14 Sep 2026

0.128

USAF contract day (+10.9%)

Motley Fool

16 Oct 2026

0.120

Latest close (+14.3%)

StockAnalysis

Valuation Multiples

MultipleTitomicBasis

Market capitalisation (AUD Mn)

About 214

About 1,786M shares × A$0.12

Enterprise value (AUD Mn)

About 205

Market cap less about A$25M pro-forma cash (Jun-26 cash A$14.3M plus about A$15.6M net placement less Q3 burn; estimate) plus about A$16M debt and leases

EV / Sales (TTM revenue A$9.94M, S&P to Jun 2026)

About 20.6x

Estimate

P/E

n/m (loss-making)

—

EV / EBITDA

n/m (negative EBITDA)

—

P/B

About 4.5–5.0x

Estimated equity of about A$44M (Dec-25 equity A$47.8M, less H1 2026 loss, plus placement)

Analyst Conclusions

Management guidance (latest)

  • Revenue growth expected for the remainder of 2026, driven by defence contracts, energy, maritime sustainment and machine sales (Appendix 4D, Aug 2026).

  • Growth in customer orders and receipts expected in H2 2026 (Q2 2026 4C).

  • Cash flow and EBITDA break-even during 2027 (Q2 2026 4C; placement; restructure).

  • About A$3.0M of annualised cost savings, with the restructure complete by end Oct 2026.

  • Redomicile implementation expected by 30 Nov 2026.

  • Long-range: US$750M revenue by 2030 (Aug 2025); 13 conversion programs with illustrative US$250–430M revenue potential over 2026–2030 (not a forecast).

Consensus growth expectations

Not publicly available in verifiable form. Ord Minnett's Hold rating and A$0.18 target (Sep 2026) imply limited conviction in near-term delivery.

Bull case

  1. Inflection in defence adoption. In about six weeks (Sep–Oct 2026), Titomic announced a US$5.0M USAF depot system, a Navy FRC Southwest order, a Bechtel Plant Machinery submarine-base evaluation and a Royal Netherlands Army prototype. If depot adoption replicates across USAF and Navy sites, revenue could step up sharply in 2027.

  2. Production conversion is real, not theoretical. The semiconductor LRIP converted to full-rate production, and a defence-prime EMD article was delivered and tested. Both are evidence that the qualification-to-production pathway works and supports recurring revenue.

  3. Funding gap could close non-dilutively. An EXIM loan of about US$10M, plus potential OSC capital, alongside A$3.0M of savings and tapering capex (Huntsville build-out "substantially complete"), could bridge the company to 2027 break-even without further deep-discount equity.

Bear case

  1. Revenue is shrinking while losses widen. H1 2026 revenue fell 11.1% to A$4.87M while the net loss rose 45.3% to A$19.35M. Unit economics (gross margin of 12% in FY2025 and negative on a trailing basis) remain far from break-even, and a peer (AML3D) shows what good economics look like in the same niche.

  2. Serial dilution and execution slippage. Share count is up about 9-fold since FY2022. The September 2026 raise came at a 23.5% discount. Redomicile timetables have slipped twice, and Q2 receipts disappointed, all of which erodes credibility of the US$750M 2030 target.

  3. Order sizes are small relative to burn. Most 2026 orders are A$0.2–1.2M against roughly A$8M of quarterly operating outflow. Even the US$5.0M USAF order represents less than one quarter of cash burn, so many more wins, or a single large program, are needed.

Key catalysts and monitorables (next 12 months)

TimingCatalyst / monitorableWhat to watch
Late Oct 2026Q3 2026 Appendix 4CCustomer receipts recovering above about A$3M per quarter; operating outflow trending below A$7M
Q4 2026EXIM and OSC funding decisionsLoan quantum, terms, covenants
By 30 Nov 2026Scheme meeting, court approval and implementationVote outcome; CDI mechanics; US listing timeline
H2 2026 – H1 2027Prime program progression beyond EMDLRIP order from the unnamed defence prime
Dec 2026USAF system delivery and acceptance; TKF™623 deliveries (energy company, Compass Systems)Revenue recognition timing
Feb–Mar 2027CY2026 annual report (first full calendar year)Gross margin recovery; restructure savings visible
2,027Semiconductor full-rate revenue (about A$1.5M); break-even trajectoryEvidence of recurring revenue mix
OngoingFurther equity issuanceSize and discount of any future raise

Concluding analyst verdict

Titomic is a credible technology company that has not yet become a credible business. Over 2024–2026 it accomplished a great deal operationally. It relocated its centre of gravity to Huntsville, built an AS9100-certified plant, recruited a defence-heavy board, secured DNV qualification, and won marquee validations from the USAF, the US Navy depot system, Bechtel Plant Machinery, Lufthansa Technik and a semiconductor customer now in full-rate production. The September–October 2026 newsflow is the strongest commercial run in the company's history, and it supports the view that TKF™ has a defensible role in defence sustainment and niche production.

The financial record, however, remains the binding constraint. Revenue of about A$10M on a trailing basis sits against net losses of about A$37M over the last twelve months (TP2025 and H1 2026 combined). Gross margins have deteriorated, H1 2026 revenue declined, and the balance sheet required a discounted A$16.5M placement after funding fell to 1.7 quarters. The US$750M-by-2030 ambition is not a useful valuation anchor; the 2027 break-even target is the relevant test.

At about A$0.12 per share (EV about A$205M, about 20x trailing sales), the market is still paying a substantial premium for optionality. That premium is justified only if 2027 delivers three things: multi-million-dollar recurring production contracts, gross margins approaching the 35–60% range seen in FY2024 and at peers, and non-dilutive US funding.

Verdict: Speculative / Hold. Titomic offers high-beta exposure to Western defence-industrial reshoring with genuine technology validation. Risk-reward hinges on Q3–Q4 2026 cash receipts, EXIM/OSC outcomes and successful redomiciliation. Investors should size positions for the material probability of further dilution, and should weight hard evidence of conversion (receipts and margins) above announcements of orders and partnerships.


Principal sources: Titomic ASX announcements and releases (FY2025 Annual Report release 28 Aug 2025; TP2025 Annual Report 27 Feb 2026; Q2 2026 Quarterly Activities Report and Appendix 4C 31 Jul 2026; Appendix 4D H1 2026 31 Aug 2026; placement, contract, scheme, AGM and restructure releases Mar–Oct 2026); titomic.com news pages; S&P Global Market Intelligence data via StockAnalysis.com; Quartr event summaries; Simply Wall St; TipRanks; MarketScreener; Kalkine; Discovery Alert; SmallCaps; Mining.com.au; The Motley Fool Australia; Proactive Investors; Australian Manufacturing; Business Wire (2020–2021); AML3D Appendix 4E and results release (31 Aug 2026). Figures marked "derived" or "estimate" are analyst calculations from these sources.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenurePrior roles / backgroundTotal remuneration (latest disclosed)

Jim Simpson

CEO and Managing Director (Director since 10 Jan 2025)

CEO since 2024; previously US President

Aerospace and defence executive; recruited to lead US expansion

A$861.6k total (about 61% salary, 39% bonus/equity), per Simply Wall St summary of the latest remuneration report; holds about 0.36%

Dag W. R. Strømme

Executive Chair

Board since 1 Jul 2020; Chair since 2 Oct 2023; Executive Chair since 2024

Former MD, Morgan Stanley (2001–2007); Chair of Axactor ASA (2017–2018); Co-Chair PAACS Invest AS; Chair Racom AS

A$227.7k (latest disclosed); held about 30.6M shares (1.9%) at Dec 2025 and exercised 52.5M options in Sep 2026

Geoff Hollis

CFO and Company Secretary

Since 2024

CFO and Company Secretary, Lifestyle Communities (2011–2018); CFO, Victory Offices (2019–2020); Company Secretary, Imagion Biosystems (2024); Chartered Accountant

A$948.1k (latest disclosed)

Dr Patti Dare

President, Titomic USA

—

US operations leader; media contact

—

Chris Myers

President, Titomic Europe

Since early 2026

Not publicly disclosed in reviewed sources

—

Ferdy Touwen

Deputy President and Head of European Operations

Since early 2026

Promoted internally

—

Klaas Rozema

Senior Executive Advisor (planned sabbatical)

Founder of Dycomet; GM Titomic Europe from Nov 2021

Founded Dycomet (2006)

Not separately verified

“—” = not publicly disclosed.

Board of Directors

DirectorRoleIndependenceAppointedNotes

Dag W. R. Strømme

Executive Chair

Non-independent (executive)

1 Jul 2020

Re-elected at the Sep 2026 AGM with 99.38% support

Jim Simpson

CEO and Managing Director

Non-independent (executive)

10 Jan 2025

—

Humphrey Nolan

Deputy Chair, Non-Executive Director

Independent

1 Jul 2020

Chair of Nolan Group and Tapex Group; re-elected Sep 2026 (99.44%); holds about 3.31%

Mira Ricardel

Non-Executive Director

Independent

2021

Principal, Chertoff Group; former senior US government official; sold 1.7M shares at A$0.225 on 7 Apr 2026

Lt Gen (ret.) John Frewen AO DSC

Non-Executive Director

Independent

1 Jul 2025

Former senior Australian Army officer

Lt Gen (ret.) Henry "Trey" Obering III

Non-Executive Director

Independent

11 Mar 2026

Former Director, US Missile Defense Agency; elected at the Sep 2026 AGM (99.63%); 5,000,000 options approved (98.74%)

Jim Chilton

Non-Executive Director

Independent

15 Sep 2026

Boeing veteran; joined Titomic in an advisory capacity in Jan 2026; succeeds Dr Andreas Schwer

Dr Andreas Schwer

Former Chair / NED

—

About 2020/21 to Sep 2026

Retired Sep 2026 after nearly six years

Board & Management Changes

DateChangeContext

1 Jul 2025

John Frewen appointed NED

Sovereign/defence capability

6 Jan 2026

European leadership reshuffle (Myers, Touwen, Rozema)

Succession and execution focus

27 Jan 2026

Boeing veteran Jim Chilton joins Titomic

Aerospace credibility

11 Mar 2026

Lt Gen Trey Obering appointed NED

Missile defence domain

13 Feb 2026

CEO Jim Simpson sold 472,000 shares (about A$101k)

Insider selling

15 Sep 2026

Chilton joins board; Schwer retires

Board refresh

7 Sep 2026

Exec Chair Strømme exercises 52.5M options

Increases insider ownership

Major Shareholders

HolderStakeDate / basisSource

Regal Partners Limited

About 8.5%

Ownership summary c. 2025; Regal traded large blocks around Jun–Jul 2025

Simply Wall St

Maybank Securities Pte Ltd (asset management arm)

8.09% (up from 7.49%)

Substantial holder notice c. Jun 2025; further purchases Aug–Nov 2025

TipRanks / Simply Wall St

Morgan Stanley and subsidiaries

7.65%

Substantial holder notice (2025)

TipRanks

Macquarie Group

About 5.3% (holding changes reported 18–19 Dec 2025)

2025

Simply Wall St

Humphrey Nolan (director)

About 3.31%

Latest disclosed

Simply Wall St

Dag Strømme (Exec Chair)

1.9% at Dec 2025, plus 52.5M shares from options in Sep 2026

Director interest notices

MarketScreener

Jim Simpson (CEO)

About 0.36%

Latest disclosed

Simply Wall St

Competitive Landscape

Key Competitors

CompetitorHQ / ownershipSegment overlapRelative positioning vs Titomic

SPEE3D

Australia; private

Cold spray AM systems; expeditionary/military deployments

Closest technology peer; strong defence field-deployment profile; financials not publicly disclosed

Impact Innovations GmbH

Germany; private

High-pressure cold spray systems

Established European high-pressure OEM; financials not publicly disclosed

VRC Metal Systems

USA; private

Portable high-pressure cold spray for US defence sustainment

Direct US defence depot competitor; financials not publicly disclosed

CenterLine (Windsor) Ltd / SST

Canada; private

Low-pressure cold spray systems

Competes in low-pressure / MRO; financials not publicly disclosed

Plasma Giken

Japan; private

High-pressure cold spray systems

Asian high-pressure OEM; financials not publicly disclosed

Oerlikon (Metco)

Switzerland; listed (SIX: OERL)

Thermal spray and coatings services, including cold spray

—

AML3D Limited

Australia; ASX: AL3

Wire-arc additive manufacturing (ARCEMY®) for US Navy submarine/maritime industrial base

Most direct listed comparator for "Australian AM company scaling in the US Navy industrial base"

Velo3D

USA; listed

Laser powder-bed fusion for space/defence

—

Nikon SLM Solutions

Germany (Nikon-owned)

Laser powder-bed fusion systems

—

Sciaky (Phillips Service Industries)

USA; private

Electron-beam AM (large titanium parts)

Large-part metal AM alternative; financials not publicly disclosed

Conventional suppliers (forgings, castings, machining, welding repair)

Various

Incumbent repair and production routes

The main substitute Titomic displaces on lead time and capability

Peer Comparison FY2025

MetricTitomic (TTT)AML3D (AL3)

Latest annual revenue (AUD Mn)

9.4312.47

Revenue period

FY to Jun 2025 (S&P basis)

FY to Jun 2026 (incl. lease income)

Latest revenue growth (%)

22.570.0

Gross margin (%)

12.063.0

Net loss latest annual (AUD Mn)

-19.89-4.48

Net margin (%)

-210.9-35.9

Company Snapshot

2014

Founded

AL, US

Headquarters

SWOT Analysis

Strengths

  • Proprietary, broad technology platform. TKF™ covers low-, medium- and high-pressure systems (TKF™ 523, 623, 1000, 3250) for manufacturing, coating and repair (Q2 2026 report).
  • Certified US production capacity. AS9100 certification (Apr 2026) and a 59,000 sq ft Huntsville plant with metrology and machining (Q2 2026 report).
  • Depot-level defence validation. US$5.0M USAF system order (Sep 2026) and a Navy FRC Southwest order via Compass Systems for more than US$400k (Oct 2026).
  • Production proof point. Semiconductor LRIP converted to full-rate production (about A$1.5M in 2027; up to A$3.2M in 2028).
  • Independent qualifications. DNV Statement of Qualification for oil and gas aluminium coatings (Apr 2026).
  • Blue-chip aerospace MRO reference. About five years with Lufthansa Technik; contract worth more than A$1.2M (May 2026).
  • High-calibre defence board and advisers. Former MDA Director Obering, Lt Gen Frewen, former US official Ricardel, Boeing veteran Chilton; strategic advisory groups in both the US and Europe.

Weaknesses

  • Deep, widening losses. Net loss of A$19.35M in H1 2026 (+45.3% YoY) on revenue of A$4.87M (Appendix 4D).
  • Poor unit economics. Gross margin fell from 35.9% (FY2024) to 12.0% (FY2025), and was reportedly negative in the trailing period to Dec 2025 (S&P).
  • Short runway before the September raise. The Appendix 4C at 30 Jun 2026 showed 1.7 quarters of funding (cash A$14.26M against a quarterly operating outflow of A$8.26M).
  • Lumpy collections. Customer receipts in Q2 2026 were A$1.48M, below expectations because of payment timing (4C).
  • Extreme historical dilution. Shares on issue rose from about 203M (Jun 2022) to about 1,786M (Oct 2026), roughly a 9-fold increase (S&P; ASX).
  • Governance. The Executive Chair structure is contrary to the ASX recommendation for an independent chair, and gender diversity on the board is limited (one in seven).
  • Timetable slippage. The redomicile moved from a mid-Aug 2026 target to 30 Nov 2026, with multiple ASIC AGM extensions.

Opportunities

  • Navy and USAF sustainment roll-out. If PBDE 2026 and depot orders become fleet-wide adoption, the TKF™ Tactical shipboard units could be fielded at scale.
  • Defence prime production programs. The EMD article was delivered and tested (Jun 2026), giving a pathway to program-of-record production.
  • Non-dilutive US capital. The EXIM direct loan of about US$10M is progressing, and OSC funding is being pursued, against a total target of US$25M (2026 4Cs).
  • US listing optionality. A future US exchange listing after redomicile could widen the investor base (12 Mar 2026 announcement).
  • Semiconductor and energy recurring revenue. Full-rate semiconductor production plus energy repair-as-a-service (Saudi Arabia, Norway, a major operator).
  • European rearmament. Royal Netherlands Army battle damage repair prototype, European advisory group, and the EU €800B defence investment outlook.

Threats

  • Funding risk. Failure to secure EXIM/OSC loans would likely force further discounted equity raises (the Sep 2026 placement was priced at a 23.5% discount).
  • Better-capitalised or better-performing peers. AML3D reported 63% gross margin and EBITDA-positive H2 FY2026 in the same Navy industrial base.
  • US domestic preference. Private US cold spray OEMs (e.g., VRC Metal Systems) may be favoured before redomicile completion.
  • Scheme risk. The redomicile may fail the double-majority vote, court approval or regulatory conditions, or be delayed further.
  • Program timing. US budget and contracting delays could push revenue right (the Q2 2026 orders slipped into Q3).
  • Key-person and execution risk during the restructure, with roles cut in Australia and the US (Oct 2026).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Jun 2025Huntsville 59,000 sq ft HQ and plant inauguratedUS pivot made physical
Jun 2025Maybank Securities raises stake to 8.09%Institutional support
1 Jul 2025Lt Gen (ret.) John Frewen joins boardDefence governance
Jul 2025A$50M capital raise; 200M shares quoted 31 Jul 2025Record funding
28 Aug 2025FY2025 results: revenue A$8.1M (+37%), net loss A$19.9M; US$750M-by-2030 ambition; FY-end changeStrategy reset
Aug–Nov 2025Maybank continues buying (e.g., 3.8M shares on 18 Sep 2025)Accumulation
Oct 2025Shares trade as high as about A$0.49 (per insider trade data)Peak sentiment
24 Nov 2025AGM held; all resolutions passedGovernance
19 Dec 2025Directors (Simpson, Strømme, Nolan, Ricardel, Frewen) acquire shares, consistent with approved placement participationInsider alignment
6 Jan 2026European leadership changesExecution in Europe
27 Jan 2026Jim Chilton (Boeing veteran) joins TitomicAerospace depth
28 Jan 2026Contract from Deutsche BahnRail diversification
12 Feb 2026Space Act Agreement with NASASpace validation
13 Feb 2026CEO sells 472,000 sharesInsider sale (modest)
27 Feb 2026TP2025 annual report: revenue A$5.27M, net loss A$17.85M, cash A$35.77MFirst December-basis report
11 Mar 2026Huntsville Investor DayStrategy communication
11–12 Mar 2026Plan to redomicile to the US; Lt Gen Obering appointedStructural shift
2 Apr 2026AS9100 at Huntsville; DNV oil and gas qualificationMarket access
7 Apr 2026Director Mira Ricardel sells 1.7M shares at A$0.225Insider sale
30 Apr 2026Q1 2026 Appendix 4C (operating outflow about A$7.1M)Burn visibility
12–13 May 2026Scheme Implementation Deed with Titomic, Inc.Redomicile mechanism
14 May 2026European Strategic Advisory Group formedEuropean defence access
18 May 2026Lufthansa Technik contract (more than A$1.2M)Aerospace MRO
22 May 2026Under Secretary of War (Acquisition & Sustainment) Michael Duffey visits HuntsvilleUS government visibility
25 May 2026ASIC extends AGM deadline (to 28 Aug 2026; later to 28 Sep 2026)Timetable slippage
May 2026Pacific Battle Damage Exercise 2026: TKF™ outperforms competing cold spray systems (company claim)Navy validation
11 Jun 2026Multi-year CRADA with US military research organisationGovernment R&D
12 Jun 2026Issue of securitiesCapital structure
16 Jul 2026Update on redomiciliation (timetable to be revised); change in substantial holdingDelay signalled
31 Jul 2026Q2 2026 4C: receipts A$1.5M (below expectations), operating outflow A$8.3M, cash A$14.3M, 1.7 quarters of fundingLiquidity pressure
31 Aug 2026H1 2026 results: revenue A$4.87M (-11.1%), net loss A$19.35M (+45.3%)Weak half
1–2 Sep 2026A$16.5M placement at A$0.13 (23.5% discount); shares -20.6% to A$0.14; four US orders (more than A$750k); EXIM loan progressingDilutive funding
4 Sep 2026Ord Minnett downgrades to Hold from Speculative Buy; target A$0.18Sell-side caution
7–8 Sep 2026Placement settles; Exec Chair exercises 52.5M optionsCapital structure
14 Sep 2026US$5.0M USAF cold spray system contract (Tinker AFB); shares +10.9% to A$0.128Largest single US defence order
15 Sep 2026Jim Chilton joins board; Andreas Schwer retiresBoard refresh
23 Sep 2026About A$550k oil and gas contracts in Saudi Arabia and NorwayEnergy diversification
24 Sep 2026Revised scheme timetable; implementation expected by 30 Nov 2026Redomicile delay
28 Sep 2026AGM: all resolutions passed (Obering 99.63%; Strømme 99.38%; Nolan 99.44%; Obering options 98.74%); US orders worth AU$752k announcedShareholder support
7–8 Oct 2026Full-rate semiconductor production contract (about A$1.5M in 2027; up to A$3.2M in 2028)LRIP-to-production proof point
c. 12 Oct 2026Royal Netherlands Army €150k battle damage repair prototypeEuropean defence
14 Oct 2026Compass Systems PO (more than US$400k) for two TKF™623 systems for Navy FRC SouthwestNavy depot adoption
15 Oct 2026Restructure: about A$3.0M annual savings; Australia becomes R&D centreCost discipline
c. 16 Oct 2026Bechtel Plant Machinery US$250k contract (US Navy submarine industrial base)Naval nuclear supply chain
16 Oct 2026Shares close at A$0.120 (+14.3% on the day)Sentiment uptick off lows

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Revenue by Segment: Total revenue S&P basis rose from AUD 5.3 Mn in FY2022 to AUD 9.4 Mn in FY2025.
Titomic Limited — Revenue by Segment
Series (AUD Mn)FY2022FY2023FY2024FY2025
Total revenue S&P basis5.34.57.79.4
Australia segment revenue4.433.95
USA segment revenue00.40.53.9
Europe segment revenue1.52.75.27.3
Intersegment eliminations-0.5-1.6-1.9-6.7

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.